Unlock the Editor’s Digest for free
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
Teams of bacteria in the gut help fight disease by eating the food that invading pathogens need to thrive, according to research that underscores the health benefits of fostering humans’ rich digestive ecology.
Intestinal bugs’ wide-ranging appetites have the secondary impact of starving incoming microbes that bring about infections such as salmonella and pneumonia, says the paper published in Science on Thursday.
The findings boost a growing research effort to better human resistance to bacteria that are introduced via eating and drinking but can bring about illness elsewhere in the body. They offer the prospect of making intestinal tracts more hostile to dangerous new entrants through dietary changes and bespoke supplements of beneficial bugs.
This field is becoming increasingly important as the rise in antibiotic resistance triggers a quest for alternative methods of treating and preventing bacterial diseases.
“The eureka moment was when we put groups of gut bacteria together and they acted against the pathogens,” said Kevin Foster, a professor at Oxford university and a co-author of a paper in the publication Science. “The human host, by allowing non-harmful bugs to grow, can hinder the growth of harmful ones.”
The research focused on two pathogens: Salmonella enterica Serovar Typhimurium and Klebsiella pneumoniae, which occurs in the gut naturally but can bring about diseases ranging from meningitis to urinary tract infections.
The scientists then tested 100 gut microbes to gauge their effectiveness at stopping the two invading bacteria — a phenomenon known as “colonisation resistance”.
The defending microbes offered little or no obstacle to the pathogen pair when deployed alone but were much more effective when introduced in certain combinations, the research found.
The resident gut bacteria contend with each other for food and in doing so achieve what Foster dubbed the “knock-on effect” of depriving the pathogens of nourishment.
The research adds to a growing interest in the gut microbiome as a tool to combat disease and encourage good health throughout the body.
Companies such as Microbiotica, a Cambridge-based 2016 spinout from the Wellcome Sanger set up, are working to progress therapeutics based on bugs in the digestive system.
Deeper understanding of gut microbe activity potentially opens the way to devising sophisticated “probiotic” mixes of beneficial bugs, according to a commentary published separately in Science on Thursday and written by authors unconnected to the latest research paper.
“[This] could allow clinicians to administer tailored probiotic communities that hinder difficult or impossible-to-treat infections from occurring in the first place,” write the commentary’s co-authors, Lauren Radlinski and Prof Andreas Bäumler of the University of California Davis.
